Understand the business
Explore companies classified in biotech research, with their latest reporting and business connections.
Loading profiles…
Showing 1–11 of 11 companies · Page 1 of 1
Reset filtersDeveloper of investigational switchable CAR T-cell therapies for cancer, including donor-derived candidates for acute myeloid leukemia and B-cell malignancies. No marketed therapy or product-sales revenue is established by the reviewed sources.
Public business brief · 2026-09-26
BioAmp Diagnostics develops biochemical tests intended to provide faster antibiotic-resistance information to clinicians and laboratories.
Biotechnology company developing immunotherapies and vaccines, with headquarters in Mainz, Germany.
CaroGen Corporation develops investigational RNA-based immunotherapies for infectious diseases.
CpG Diagnostics is developing a blood test to help clinicians assess ovarian-area masses before treatment.
Impetus Agriculture develops biological insect-control technology for potential agricultural sprays and crop traits.
Invasive Species Corporation develops biological controls for invasive species and resistant weeds, including Zequanox for water systems.
Link Cell Therapies develops experimental CAR-T cancer treatments designed to activate when two target markers occur together on a cell. It is developing its own treatment candidates and works with other biotechnology companies on discovery programs; no commercial therapy sales are disclosed.
Public business brief · 2026-09-30
Biopharmaceutical business developing and manufacturing biological medicines and providing contract development and manufacturing services.
Melbourne-headquartered radiopharmaceutical company developing and commercializing cancer imaging products and targeted therapies.
Cell-therapy developer that advances CAR T-cell treatments through research, clinical partnerships and licensing to commercialisation partners. Its disclosed BioOra licence provides for upfront cash, equity and royalties if licensed products generate sales.
Public business brief · 2026-10-04
Latest reporting
Published coverage connected to the companies in this selection.
Startups & growth· Analysis
· MoneyMakers
Startups & growth· Analysis
· MoneyMakers
Startups & growth· Analysis
· MoneyMakers
Startups & growth· Analysis
· MoneyMakers
Startups & growth· Analysis
· MoneyMakers
Funding & fundraising· News
· MoneyMakers
